Related Experiment Video

Updated: May 12, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

A new pediatrics for a new century

John D Lantos1, Neil A Ward

  • 1Department of Pediatrics, University of Missouri-Kansas City, 2401 Gillham Rd, Kansas City, MO 64108, USA. jlantos@cmh.edu

Pediatrics
|April 3, 2013
PubMed

Insights

Pediatrics may not be fully serving children's health, requiring a reevaluation of resource allocation. Balancing cost-effectiveness with individual commitments is crucial for improving child health outcomes.

Area of Science:

  • Pediatric health outcomes
  • Healthcare system analysis
  • Bioethics and resource allocation

Background:

  • Growing concerns suggest pediatrics may not be optimizing child health.
  • Current pediatric practices face scrutiny regarding their effectiveness and direction.

Discussion:

  • The core challenge involves balancing utilitarian resource allocation (e.g., cost-effectiveness) with deontological principles (prioritizing individual commitments).
  • Implementing necessary changes requires significant social engineering across healthcare, education, and public health sectors.
  • The current system's inertia risks perpetuating suboptimal care for children.

Key Insights:

  • A fundamental recalibration is needed between economic efficiency and ethical obligations in pediatric care.
  • Systemic reform is essential, impacting healthcare delivery, educational frameworks, and public health initiatives.
  • The success of pediatrics is intrinsically linked to the future health of society.

Outlook:

  • Future pediatric practice must adapt to ensure optimal health for all children.
  • Failure to evolve risks a continued deficit in child health and societal well-being.
  • Proactive systemic adjustments are imperative for advancing pediatric health and its societal impact.

More Related Videos

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including: